Publication date: May 22, 2026
Pregnant and lactating women face heightened risk of mortality due to Ebola disease during outbreaks, yet have historically been excluded from vaccine trials and emergency vaccination campaigns. This study assessed willingness to receive an Ebola vaccine and identified associated factors among pregnant and lactating women in Kampala-Uganda, in the aftermath of the 2022 Sudan ebolavirus outbreak and amid the COVID-19 pandemic. A cross-sectional survey was conducted in 2023 among pregnant/lactating women receiving antenatal/postnatal services at Kawempe National Referral Hospital. Data were collected using a structured questionnaire adapted from the WHO SAGE Working Group on Vaccine Hesitancy and included additional items on Ebola vaccine attitudes, socio-demographics, prior vaccination experiences, vaccine preferences (oral vs injectable) and health status, including chronic illness. The primary outcome was willingness to receive an Ebola vaccine. Modified Poisson regression was done using STATA version 15 and a p-value
| Concepts | Keywords |
|---|---|
| Ebolavirus | COVID-19 vaccination |
| Hospital | Ebola vaccine acceptability |
| Postnatal | Lactating women |
| Sudan | Pregnant women |
| Women | Uganda |
| Vaccine hesitancy |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | face |
| disease | MESH | emergency |
| disease | MESH | COVID-19 pandemic |
| disease | MESH | included |
| disease | MESH | chronic illness |